Nicotine Decreases Bradykinesia-rigidity in Haloperidol-treated Patients with Schizophrenia

By Yang Y.K.   Nelson L.   Kamaraju L.   Wilson W.   McEvoy J.P.  

Neuropsychopharmacology, Vol. 27, Iss. 4, 2002-10 ,pp. : 684-686

Elsevier

Access to resources Recommend Favorite

Frequency of Extrapyramidal Adverse Reactions in Schizophrenic Outpatients Treated with Risperidone, Olanzapine, Quetiapine or Haloperidol: Results of the EIRE Study

By Bobes J.  

Clinical Drug Investigation, Vol. 22, Iss. 9, 2002-01 ,pp. : 609-622

Adis International

Access to resources Recommend Favorite

Prevention of relapse in schizophrenia with clozapine: an open mirror-image study of 53 outpatients treated up to 8 years

By Klimke A.   Klieser E.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 343-343

Elsevier

Access to resources Recommend Favorite

Abnormal thermoregulation in drug-free male schizophrenia patients

By Shiloh R.   Weizman A.   Epstein Y.   Rosenberg S.-L.   Valevski A.   Dorfman-Etrog P.   Wiezer N.   Katz N.   Munitz H.   Hermesh H.  

European Neuropsychopharmacology, Vol. 11, Iss. 4, 2001-08 ,pp. : 285-288

Elsevier

Access to resources Recommend Favorite

Pramipexole as adjunct to haloperidol in schizophrenia - Safety and efficacy

By Kasper S.   Barnas C.   Heiden A.   Volz H.P.   Laakmann G.   Zeit H.   Pfolz H.  

European Neuropsychopharmacology, Vol. 7, Iss. 1, 1997-02 ,pp. : 65-70

Elsevier

Access to resources Recommend Favorite